Vertex Pharmaceuticals Inc
XHAM:VX1
Vertex Pharmaceuticals Inc
XHAM:VX1
Price:
384.75
EUR
0.07%
Market Closed
Market Cap:
€39.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
V
|
Vertex Pharmaceuticals Inc
XHAM:VX1
|
US |
|
C
|
Carlisle Companies Inc
XMUN:CLE
|
US |
|
S
|
Steel Dynamics Inc
BMV:STLD
|
US |
|
D'Ieteren Group NV
F:DJDA
|
BE |
|
Centene Corp
NYSE:CNC
|
US |
|
GAIL (India) Ltd
LSE:GAIA
|
IN |
|
A
|
Axon Enterprise Inc
SWB:TCS
|
US |
|
B
|
Booking Holdings Inc
F:PCE1
|
US |
|
F
|
F5 Inc
XETRA:FFV
|
US |
|
M
|
Mediobanca Banca di Credito Finanziario SpA
F:ME9
|
IT |
|
Hitachi Ltd
F:HIA1
|
JP |
|
SK Innovation Co Ltd
KRX:096770
|
KR |
|
H
|
Hamborner REIT AG
LSE:0MCG
|
DE |
|
J
|
J B Hunt Transport Services Inc
XBER:JB1
|
US |
Multiples-Based Value
The Multiples-Based Value for 
Vertex Pharmaceuticals Inc (VX1) under the Base Case is hidden
EUR.
Compared with the current market price of 384.75 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
VX1 Multiples-Based Value
LOCKED
